MedTrace Logo

Ultrasound Guided Knee Injections in Musculoskeletal Medicine

NCT03293238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2022-08-08

Study results available
· View outcomes & findings →

Summary

This study will compare the accuracy and patient reported outcomes between four different techniques used to perform a knee injection.

Conditions

Interventions

PROCEDURE

Joint line ultrasound

Patients will be sitting with knee bent at 90 degrees. Clinician will palpate extremity to determine if a medial or lateral approach will be made for the injection of Euflexxa into the joint space. The procedure will be aided by real time visualization utilizing ultrasound guidance.

PROCEDURE

Joint line landmark

Patients will be sitting with knee bent at 90 degrees. Clinician will palpate extremity to determine if a medial or lateral approach will be made for the injection of Euflexxa into the joint space. The procedure will not be aided by ultrasound guidance, but completed based strictly on tactile feedback from the injecting physician.

PROCEDURE

Suprapatellar ultrasound guided

Patients will be lying supine on exam table. Ultrasound will be used to capture a longitudinal view of the proximal patella and the plane between the prefemoral fat pad and suprapatellar fat pad. After the desired visualization is achieved, injection of Euflexxa will be made within the suprapatellar pouch.

PROCEDURE

Suprapatellar Landmark

Patients will be lying supine on exam table. Injecting physician will insert needle lateral to the vastus lateralis toward the suprapatellar pouch, and will inject of Euflexxa once it is believed that the needle tip is in the pouch.

Sponsors & Collaborators

  • American Medical Society for Sports Medicine (AMSSM)

    collaborator UNKNOWN

  • Andrews Research & Education Foundation

    lead OTHER

Principal Investigators

  • Joshua Hackel, MD · Andrews Institute for Orthopaedic & Sports Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-03
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03293238 on ClinicalTrials.gov